Blood volume determination, a nuclear medicine test in evolution

Area of Science:

• Cardiovascular Physiology
• Nuclear Medicine
• Diagnostic Imaging

Background:

• Historical methods for blood volume determination, including dye dilution and dual-isotope techniques, faced limitations such as rapid clearance and procedural complexity.
• The dual-isotope technique, while established, required on-site labeling and extensive preparation, resulting in long processing times (6-8 hours).

Purpose of the Study:

• To introduce and evaluate an updated, FDA-approved single-isotope method for blood volume determination.
• To compare the efficiency and accuracy of the single-isotope method against previous techniques.

Main Methods:

• The single-isotope method utilizes radioiodine 131-labeled human serum albumin (HSA), with test doses and standards provided in kit form.
• Red cell volume is calculated using measured plasma volume and average whole-body hematocrit.
• A dedicated microprocessor performs calculations and generates reports, with results compared to predicted normal values based on weight and sex.

Main Results:

• The single-isotope method significantly reduces determination time, with preliminary results in 30 minutes and complete calculations in 90 minutes.
• This method is currently employed in over 60 major institutions, indicating widespread adoption and acceptance.
• The new method simplifies the process by eliminating on-site labeling and complex standard preparation.

Conclusions:

• The single-isotope method represents a substantial advancement in blood volume determination, offering improved speed and efficiency.
• This streamlined approach enhances diagnostic capabilities in clinical settings.
• The method provides accurate and reliable blood volume measurements crucial for patient management.